Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07265323 · ClinicalTrials.gov registry record · NA
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
A NA study of Insulin Sensitivity and Alzheimer Blood Biomarkers, sponsored by Pennington Biomedical Research Center.
- Recruiting
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT07265323 is a NA study of Insulin Sensitivity and Alzheimer Blood Biomarkers that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 8 participants, below the 73-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07265323, a NA study of Insulin Sensitivity and Alzheimer Blood Biomarkers, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to determine if a weekly delivery of insulin at short intervals lasting up to 2 hours can improve insulin sensitivity and cognition in adults with Alzheimer's Disease. It will also provide information about the safety and feasibility of this intervention. The main questions it aims to answer are: Does the intervention improve insulin sensitivity (how the body uses glucose)? Does the intervention improve cognition, measured by the Montreal Cognitive Assessment (MoCA) and the Revised Memory and Behavior Problems Checklist (RMBPC)? What changes occur in brain glucose uptake (FDG-PET)? Participants will: Receive the intervention once a week for 6 months, with each session lasting up to 2 hours Complete cognitive assessments. Adverse events will be assessed throughout the study.
Conditions Studied
Interventions
- OTHER Physiological Insulin Intervention
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2025-12 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07265323
The ClinicalTrials.gov registry entry for NCT07265323 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 73-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (89% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Insulin Sensitivity appearing as the primary indexed condition, and to 1 intervention - of which Physiological Insulin Intervention is the first listed.
NCT07265323 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT07265323 about?
NCT07265323 is a clinical study titled "Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition". The goal of this clinical trial is to determine if a weekly delivery of insulin at short intervals lasting up to 2 hours can improve insulin sensitivity and cognition in adults with Alzheimer's Disease. It will also provide information about the safety and feasibility of this intervention. The main...
What is the current status of trial NCT07265323?
This trial is currently recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2025-12. Estimated completion is 2027-05.
What conditions does trial NCT07265323 study?
This clinical trial studies the following conditions: Insulin Sensitivity, Alzheimer Blood Biomarkers, Alzheimer s Disease.
What interventions are being tested in trial NCT07265323?
The interventions under investigation include: Physiological Insulin Intervention (OTHER).
Who is sponsoring clinical trial NCT07265323?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07265323 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Sensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Countermeasures to Circadian Misalignment
RECRUITING · NA
-
Effect of Pulsatile Hormone Administration on Insulin Action
RECRUITING · NA
-
Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
RECRUITING · NA
-
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.